scholarly journals Immune thrombocytopenic purpura with subsequent development of JAK2 V617F-positive essential thrombocythemia: Case Report

2021 ◽  
pp. 018-020
Author(s):  
Hurtado-Castillo Marisabel ◽  
Flaherty Brian ◽  
Jrada Morris
Keyword(s):  
Case Report ◽  
Essential Thrombocythemia ◽  
Immune Thrombocytopenic Purpura ◽  
Subsequent Development ◽  
Jak2 V617f ◽  
Thrombocytopenic Purpura

Case report: a pregnant woman with immune thrombocytopenic purpura and unusual red cell antibodies

2020 ◽  
Vol 11 (4) ◽  
pp. 153-155
Author(s):  
Carmela R. Nanton ◽  
Sharon M. Martin ◽  
Lloyd O. Cook ◽  
Patricia J. Larison
Keyword(s):  
Case Report ◽  
Pregnant Woman ◽  
Immune Thrombocytopenic Purpura ◽  
Red Cell ◽  
Thrombocytopenic Purpura

scholarly journals Immune Thrombocytopenic Purpura Secondary to Cytomegalovirus Infection: A Case Report

2015 ◽  
Vol 2 ◽  
Author(s):  
Bessy S. Flores-Chang ◽  
Carlos E. Arias-Morales ◽  
Francis G. Wadskier ◽  
Sorab Gupta ◽  
Nicoleta Stoicea
Keyword(s):  
Case Report ◽  
Immune Thrombocytopenic Purpura ◽  
Cytomegalovirus Infection ◽  
Thrombocytopenic Purpura

scholarly journals Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case Report

2020 ◽  
Vol 13 (2) ◽  
pp. 675-679
Author(s):  
Afra M. Elhassan ◽  
Arwa Alsaud ◽  
Mohamed A. Yassin ◽  
Mahmood Aldapt ◽  
Lubna Riaz ◽  
...  
Keyword(s):  
Platelet Count ◽  
Case Report ◽  
Essential Thrombocythemia ◽  
Myeloproliferative Neoplasms ◽  
Jak2 V617f ◽  
Favorable Outcome ◽  
Who Criteria ◽  
Icu Admission ◽  
Calr Mutation ◽  
Clonal Abnormalities

Essential thrombocythemia (ET) is one of the myeloproliferative neoplasms, characterized by persistent thrombocytosis, platelets >450,000/μL, and evident clonal abnormalities like JAK2 V617F, MPL, CALR mutation and not fulfilling WHO criteria for MDS, CML, PV, and IDA. Here we report a 24-year-old female who presented with headache and was found to have thrombocytosis with a platelet count of 2,141 × 103/μL, diagnosed as ET as per WHO criteria 2008; she required ICU admission and thrombocytapheresis with a favorable outcome.

Treatment of Chronic Immune Thrombocytopenic Purpura with Homeopathic Dilutions of Patient Blood

2018 ◽  
Vol 25 (2) ◽  
pp. 114-116
Author(s):  
Heiner Frei
Keyword(s):  
Case Report ◽  
Oral Administration ◽  
Effective Treatment ◽  
Immune Thrombocytopenic Purpura ◽  
Capillary Blood ◽  
Normal Range ◽  
Thrombocytopenic Purpura ◽  
Chronic Immune Thrombocytopenic Purpura ◽  
Chronic Itp ◽  
Treatment Onset

Background: Conventional or homeopathic treatment of chronic immune thrombocytopenic purpura (ITP) is often difficult. The use of homeopathic dilutions of patient blood (HPB) for immunomodulation has been described, which inspired us to try the method in an ITP case. Case Report: A 2-year-old girl with chronic ITP was treated with homeopathic dilutions of her own capillary blood, given orally over 5 months. Immediately after treatment onset there was a rapid normalization of the thrombocyte counts. Within 6 weeks, they rose from 15,000/µl to 254,000/µl. After treatment stop, they decreased to 155,000/µl, increased again spontaneously to 270,000/µl and remained within normal range for over 3 years. Conclusions: Oral administration of homeopathic dilutions of capillary patient blood may possibly be an effective treatment in chronic ITP. If our results can be reproduced, this will revolutionize the treatment of ITP.

scholarly journals Occurrence of immune thrombocytopenic purpura in a patient with essential thrombocythemia: How the immune system can overcome a neoplastic clone

2020 ◽  
Vol 8 (11) ◽  
pp. 2132-2134
Author(s):  
Antonio Carruale ◽  
Francesco Longu ◽  
Francesca Mura ◽  
Giovanni Caocci ◽  
Giorgio La Nasa ◽  
...  
Keyword(s):  
Immune System ◽  
Essential Thrombocythemia ◽  
Immune Thrombocytopenic Purpura ◽  
Thrombocytopenic Purpura
Sign in / Sign up

Export Citation Format

Share Document